Mehdi Shakibaei

Prof. Dr. Mehdi Shakibaei

Department of Anatomy, Ludwig-Maximilians-Universität München, Munich, Bavaria, Germany
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2002 in Journal of Biomedical Materials Research
Verified
Journal Article
Closed access
PDF file
HZH. Zreiqat
H. Zreiqat
CHC. R. Howlett
C. R. Howlett
AZAndrew Zannettino
Andrew Zannettino
PEP. Evans
P. Evans
GSG. Schulze‐Tanzil
G. Schulze‐Tanzil
Mehdi ShakibaeiMehdi Shakibaei
Mehdi Shakibaei

1 May 2007 in Biochemical Pharmacology
Verified
Journal Article
Closed access
Mehdi ShakibaeiMehdi Shakibaei
Mehdi Shakibaei
TJThilo John
Thilo John
GSGundula Schulze-Tanzil
Gundula Schulze-Tanzil
ILIngo Lehmann
Ingo Lehmann
Ali MobasheriAli Mobasheri
Ali Mobasheri

1 July 2004 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
JTJens Titze
Jens Titze
Mehdi ShakibaeiMehdi Shakibaei
Mehdi Shakibaei
MSMarkus Schafflhuber
Markus Schafflhuber
GSGundula Schulze-Tanzil
Gundula Schulze-Tanzil
MPMarkus Porst
Markus Porst
KHKarl F. Hilgers
Karl F. Hilgers
Osmotically inactive skin Na+storage is characterized by Na+accumulation without water accumulation in the skin. Negatively charged glycosaminoglycans (GAGs) may be important in skin Na+storage. We investigated changes in skin GAG content and key enzymes of GAG chain polymerization during osmotically inactive skin Na+storage. Female Sprague-Dawley rats were fed a 0.1% or 8% NaCl diet for 8 wk. Skin GAG content was measured by Western blot analysis. mRNA content of key dermatan sulfate polymerization enzymes was measured by real-time PCR. The Na+concentration in skin was determined by dry ashing. Skin Na+concentration during osmotically inactive Na+storage was 180–190 mmol/l. Increasing skin Na+coincided with increasing GAG content in cartilage and skin. Dietary NaCl loading coincided with increased chondroitin synthase mRNA content in the skin, whereas xylosyl transferase, biglycan, and decorin content were unchanged. We conclude that osmotically inactive skin Na+storage is an active process characterized by an increased GAG content in the reservoir tissue. Inhibition or disinhibition of GAG chain polymerization may regulate osmotically inactive Na+storage.

4 November 2009 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
CCConstanze Csaki
Constanze Csaki
Ali MobasheriAli Mobasheri
Ali Mobasheri
Mehdi ShakibaeiMehdi Shakibaei
Mehdi Shakibaei
Introduction: Currently available treatments for osteoarthritis (OA) are restricted to nonsteroidal anti-inflammatory drugs, which exhibit numerous side effects and are only temporarily effective. Thus novel, safe and more efficacious anti-inflammatory agents are needed for OA. Naturally occurring polyphenolic compounds, such as curcumin and resveratrol, are potent agents for modulating inflammation. Both compounds mediate their effects by targeting the NF-κB signalling pathway. Methods: We have recently demonstrated that in chondrocytes resveratrol modulates the NF-κB pathway by inhibiting the proteasome, while curcumin modulates the activation of NF-κB by inhibiting upstream kinases (Akt). However, the combinational effects of these compounds in chondrocytes has not been studied and/or compared with their individual effects. The aim of this study was to investigate the potential synergistic effects of curcumin and resveratrol on IL-1β-stimulated human chondrocytes in vitro using immunoblotting and electron microscopy. Results: Treatment with curcumin and resveratrol suppressed NF-κB-regulated gene products involved in inflammation (cyclooxygenase-2, matrix metalloproteinase (MMP)-3, MMP-9, vascular endothelial growth factor), inhibited apoptosis (Bcl-2, Bcl-xL, and TNF-α receptor-associated factor 1) and prevented activation of caspase-3. IL-1β-induced NF-κB activation was suppressed directly by cocktails of curcumin and resveratrol through inhibition of Iκκ and proteasome activation, inhibition of IκBα phosphorylation and degradation, and inhibition of nuclear translocation of NF-κB. The modulatory effects of curcumin and resveratrol on IL-1β-induced expression of cartilage specific matrix and proinflammatory enzymes were mediated in part by the cartilage-specific transcription factor Sox-9. Conclusions: We propose that combining these natural compounds may be a useful strategy in OA therapy as compared with separate treatment with each individual compound.

29 June 2022 in Life Sciences
Verified
Journal Article
Closed access
MMMahzad Motallebi
Mahzad Motallebi
MBMohammed Bhia
Mohammed Bhia
HRHuda Fatima Rajani
Huda Fatima Rajani
IBIman Bhia
Iman Bhia
HTHadi Tabarraei
Hadi Tabarraei
Mehdi ShakibaeiMehdi Shakibaei
Mehdi Shakibaei

4 November 2021 in Cells
Verified
Journal Article
Open access
PDF file
AMAnna-Lena Müller
Anna-Lena Müller
ZPZahra Payandeh
Zahra Payandeh
NMNiloufar Mohammadkhani
Niloufar Mohammadkhani
SMShaden M H Mubarak
Shaden M H Mubarak
AZAlireza Zakeri
Alireza Zakeri
Mehdi ShakibaeiMehdi Shakibaei
Mehdi Shakibaei
Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and progressive autoimmune disease affecting many people worldwide. While patients show very individual courses of disease, with RA focusing on the musculoskeletal system, joints are often severely affected, leading to local inflammation, cartilage destruction, and bone erosion. To prevent joint damage and physical disability as one of many symptoms of RA, early diagnosis is critical. Auto-antibodies play a pivotal clinical role in patients with systemic RA. As biomarkers, they could help to make a more efficient diagnosis, prognosis, and treatment decision. Besides auto-antibodies, several other factors are involved in the progression of RA, such as epigenetic alterations, post-translational modifications, glycosylation, autophagy, and T-cells. Understanding the interplay between these factors would contribute to a deeper insight into the causes, mechanisms, progression, and treatment of the disease. In this review, the latest RA research findings are discussed to better understand the pathogenesis, and finally, treatment strategies for RA therapy are presented, including both conventional approaches and new methods that have been developed in recent years or are currently under investigation.